Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement Dose Escalation Trials Help Foster Success – NCCAM’s Berman

This article was originally published in The Tan Sheet

Executive Summary

Initial dose escalation trials will improve the success rate of dietary supplement clinical trials, according to director of NCCAM's Office of Clinical & Regulatory Affairs, Jonathan Berman, MD, PhD

You may also be interested in...



Inadequate Plant Characterization Plagues Trials, AERs – UCLA’s Hardy

Preliminary data suggests the characterization of plants cited in adverse event reports published in medical literature is "woefully inadequate," according to Mary Hardy, MD, University of California - Los Angeles, Center for Dietary Research in Botanicals

Inadequate Plant Characterization Plagues Trials, AERs – UCLA’s Hardy

Preliminary data suggests the characterization of plants cited in adverse event reports published in medical literature is "woefully inadequate," according to Mary Hardy, MD, University of California - Los Angeles, Center for Dietary Research in Botanicals

Inadequate Plant Characterization Plagues Trials, AERs – UCLA’s Hardy

Preliminary data suggests the characterization of plants cited in adverse event reports published in medical literature is "woefully inadequate," according to Mary Hardy, MD, University of California - Los Angeles, Center for Dietary Research in Botanicals

Related Content

Topics

UsernamePublicRestriction

Register

PS098853

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel